Patients | Age | Sex | Initial visual acuity | Initial steroid treatment | Follow up period with (period of UBM study in the remission phase) | Final visual acuity |
---|
1 | 44 | F | R 30 cm/CF | high dose | 73 months (60 months) | R 1.2 |
| | | L 0.9 | | | L 1.2 |
| | | | | | |
2 | 56 | M | R 0.9 | high dose | 73 months (61 months) | R 1.0 |
| | | L 0.7 | | | L 1.2 |
| | | | | | |
3 | 59 | M | R 1.2 | oral | 32 months (19 months) | R 1.5 |
| | | L 1.0 | | | L 1.0 |
| | | | | | |
4 | 48 | F | R 1.0 | pulse | 25 months (12 months) | R 1.2 |
| | | L 1.2 | | | L 1.2 |
| | | | | | |
5 | 33 | F | R 1.5 | oral | 25 months (12 months) | R 1.5 |
| | | L 1.0 | | | L 1.2 |
| | | | | | |
6 | 45 | M | R 0.6 | pulse | 25 months (25 months) | R 1.0 |
| | | L 0.6 | | | L 1.2 |
| | | | | | |
7 | 27 | M | R 0.7 | pulse | 25 months (25 months) | R 1.5 |
| | | L 0.3 | | | L 1.0 |